HQH logo

abrdn Healthcare Investors Shares of Beneficial Interest (HQH)

$19.93

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on HQH

AUM

$943560459

P/E ratio

--

Dividend yield

11.2477%

Expense ratio

1.19%

Beta

0.776901

Price on HQH

Previous close

$19.13

Today's open

$19.18

Day's range

$19.18 - $20.05

52 week range

$17.14 - $24.85

Profile about HQH

Headquarters

US

Exchange

New York Stock Exchange

Issue type

Common Stock

HQH industries and sectors

Industries

Health

News on HQH

Real Estate On Sale: Locking In +9% Cash Yields

Elevated interest rates push property cap rates higher, creating historically attractive entry multiples for institutional REIT buyers. CEFs transform low-yielding institutional REIT holdings into monthly cash checks. Cohen & Steers Quality Income Realty Fund Inc. holds high-conviction stakes in premier blue-chip REITs, consistently outperforming the passive VNQ benchmark across full economic cycles.

news source

Seeking Alpha • Sep 19, 2026

news preview

HQH: Over 10% Yield On This Healthcare Fund

HQH benefits from healthcare sector mean reversion after lagging the broader market for a decade. abrdn Healthcare Investors provides a lucrative 12% forward distribution yield backed by a managed distribution policy. HQH focuses primarily on small and mid cap biotech while incorporating select larger cap holdings.

news source

Seeking Alpha • Sep 18, 2026

news preview

Opportunity To Catch 2 Income Picks Before Their Yield Goes Higher

The "Base + Commission" Portfolio: Combining fixed-rate debt and preferreds with formulaic, NAV-linked variable CEFs creates a solid baseline of income with automated upside during bull markets. RVT's quarterly payout is tracking up from $0.31 to $0.33 in September, with additional regular and special year-end dividend upside in play. HQH's September payout is set to reach $0.66 per share – its highest single quarterly distribution since 2015 – with strong potential for a year-end special distribution.

news source

Seeking Alpha • Aug 22, 2026

news preview

HQH: After Biotech's Breakout Year, This Healthcare CEF Still Trades Below NAV; Buy

Abrdn Healthcare Investors is a concentrated, actively managed biotech-focused CEF trading at a 6.4% discount to NAV. I rate HQH a Buy: the fund delivered a 56% NAV return in twelve months, benefiting from an FDA regulatory shift and M&A tailwinds. The near-12% distribution is entirely funded by realized gains, not return of capital, distinguishing HQH from most high-payout CEFs.

news source

Seeking Alpha • Aug 7, 2026

news preview

2 Lower-Risk Fat Dividends You Can't Ignore

There is no universally "best" investment; successful portfolios combine complementary strengths. We discuss why dependable dividends are essential to long-term wealth creation. Our two high-yield picks provide reliable income from very different corners of the market; yields +6%.

news source

Seeking Alpha • Aug 3, 2026

news preview

Establishing A High-Yield Portfolio For Any Economic Conditions

Managed, leveraged fixed-income funds offer liquidity and instant diversification across thousands of complex institutional credit facilities. Strengthening demographic demand from an aging U.S. population delivers acyclical structural tailwinds to healthcare investments. Broad closed-end funds convert standard large- and small-cap stock movements into highly visible, managed distributions.

news source

Seeking Alpha • Jul 20, 2026

news preview

Ride The Silver Tsunami With Big Dividends; Yields +8%

Healthcare sector demand is set to surge due to global aging and declining fertility rates, driving resilient, long-term growth opportunities. As income investors, even with the most powerful tailwinds, we seek means to secure steady cash flows from our investments. We discuss our top picks to ride the Silver Tsunami, with yields +8%.

news source

Seeking Alpha • Jun 23, 2026

news preview

The Withdrawal Trap: Why Paper Wealth Fails Retirees

Always build your portfolio around your unique lifestyle goals—don't end up standing on a beach in snow pants. Mimicking ultra-wealthy founders is dangerous. Billionaires have completely different financial goals, skills, and timelines than retirees. Warren Buffett's empire relies on controlling operating companies and a massive Treasury bill hoard, not simple stock-picking.

news source

Seeking Alpha • Jun 6, 2026

news preview

HQH: GLP-1 Market Growth Offers Upside But Portfolio Structure A Bit Inefficient

abrdn Healthcare Investors offers diversified healthcare exposure with a high yield, but structural inefficiencies persist. HQH trades near its narrowest historical discount to NAV, making current valuation less attractive versus its five-year average. The fund's high payout relies on net realized gains, risking NAV erosion and inconsistent dividend coverage during sector downturns.

news source

Seeking Alpha • May 20, 2026

news preview

Variable Payouts, Permanent Income: Why I'm Buying These 11% Yields Today

Variable policies prevent funds from over-distributing and eroding the long-term capital base. HQH: Secure a 3% quarterly payout from the cutting edge of biotech and pharmaceutical innovation. USA: Get broad, large-cap exposure while maintaining a double-digit yield through five elite management teams.

news source

Seeking Alpha • Apr 22, 2026

news preview

¹ Disclosures

Get started with M1

Invest in abrdn Healthcare Investors Shares of Beneficial Interest

Open an M1 investment account to buy and sell abrdn Healthcare Investors Shares of Beneficial Interest commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in HQH on M1